Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Popliteal aneurysms. Personal experience].
Matarazzo A, Sassi O, Giordano A, Florio A, Polichetti R, De Vivo S. Matarazzo A, et al. Among authors: de vivo s. Minerva Cardioangiol. 2002 Feb;50(1):39-42. Minerva Cardioangiol. 2002. PMID: 11830717 Italian.
Prosthetic infections.
Matarazzo A, Sassi O, Florio A, De Vivo S, Mainelli R. Matarazzo A, et al. Among authors: de vivo s. Minerva Cardioangiol. 2002 Apr;50(2):143-52. Minerva Cardioangiol. 2002. PMID: 12032468 English, Italian.
Budget impact analysis of rivaroxaban vs. warfarin anticoagulation strategy for direct current cardioversion in non-valvular atrial fibrillation patients: the MonaldiVert Economic Study.
Russo V, Rago A, Papa AA, Bianchi V, Tavoletta V, DE Vivo S, Cavallaro C, Nigro G, D'Onofrio A. Russo V, et al. Among authors: de vivo s. Minerva Cardioangiol. 2018 Feb;66(1):1-5. doi: 10.23736/S0026-4725.17.04500-5. Epub 2017 Sep 25. Minerva Cardioangiol. 2018. PMID: 28948752
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience.
Russo V, Di Napoli L, Bianchi V, Tavoletta V, De Vivo S, Cavallaro C, Vecchione F, Rago A, Sarubbi B, Calabrò P, Nigro G, D'Onofrio A. Russo V, et al. Among authors: de vivo s. Int J Cardiol. 2016 Dec 1;224:454-455. doi: 10.1016/j.ijcard.2016.09.022. Epub 2016 Sep 15. Int J Cardiol. 2016. PMID: 27716588 Clinical Trial. No abstract available.
Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation.
Turco P, D'Onofrio A, Stabile G, Solimene F, La Rocca V, Vecchione F, Iuliano A, Marrazzo N, De Vivo S, Cavallaro C, Bianchi V, Agresta A, Ciardiello C, De Simone A. Turco P, et al. Among authors: de vivo s, de simone a. J Interv Card Electrophysiol. 2012 Dec;35(3):331-6; discussion 336. doi: 10.1007/s10840-012-9713-2. Epub 2012 Aug 14. J Interv Card Electrophysiol. 2012. PMID: 22890483
Single-Chamber Leadless Cardiac Pacemaker in Patients Without Atrial Fibrillation: Findings From Campania Leadless Registry.
Russo V, D'Andrea A, De Vivo S, Rago A, Manzo G, Bocchetti A, Papa AA, Giordano V, Ammendola E, Sarubbi B, Golino P, D'Onofrio A, Nigro G. Russo V, et al. Among authors: de vivo s. Front Cardiovasc Med. 2022 Jan 14;8:781335. doi: 10.3389/fcvm.2021.781335. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35097002 Free PMC article.
47 results